Medicenna Therapeutics (MDNAF) Earnings Date & Reports
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDNAF is expected to report earnings to fall 396.60% to -4 cents per share on August 08
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Est.
$-0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.03
The last earnings report on June 26 showed earnings per share of 1 cents, beating the estimate of -4 cents. With 38.15K shares outstanding, the current market capitalization sits at 47.34M.